Development of a human leukocyte antigen-based HIV vaccine.

about

Development of a human leukocyte antigen-based HIV vaccine.

Item

http://www.wikidata.org/entity/Q55447473

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Development of a human leukocyte antigen-based HIV vaccine.

@en

Development of a human leukocyte antigen-based HIV vaccine.

@nl

type

Item

label

Development of a human leukocyte antigen-based HIV vaccine.

@en

Development of a human leukocyte antigen-based HIV vaccine.

@nl

altLabel

Development of a human leukocyte antigen-based HIV vaccine

@en

prefLabel

Development of a human leukocyte antigen-based HIV vaccine.

@en

Development of a human leukocyte antigen-based HIV vaccine.

@nl

P1476

Development of a human leukocyte antigen-based HIV vaccine

@en

P2093

Yufei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques

Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412

Greater ethnic diversity correlates with lower HIV prevalence in Africa: justification for an alloimmunity vaccine.

Heterosexual and homosexual partners practising unprotected sex may develop allogeneic immunity and to a lesser extent tolerance

Alloimmunization as a strategy for vaccine design against HIV/AIDS.

Mismatched human leukocyte antigen alleles protect against heterosexual HIV transmission.

Human leukocyte antigen gene polymorphism and the histocompatibility laboratory

Immunization with recombinant HLA classes I and II, HIV-1 gp140, and SIV p27 elicits protection against heterologous SHIV infection in rhesus macaques.

Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS

Protection in simian immunodeficiency virus-vaccinated monkeys correlates with anti-HLA class I antibody response

P304

874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.13759.1

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yufei Wang

P577

2018-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29983917

http://www.w3.org/2001/XMLSchema#string

P932

6020720

http://www.w3.org/2001/XMLSchema#string